AMoon’s stake in Seer Biotech is worth $ 470 million


0


An Israeli venture capital fund for health technology and life sciences, aMoon, has generated impressive returns on its investment in the American life sciences company Seer Biotech. AMoon invested several tens of millions of dollars in Seer when it was an early stage startup. Protein Analyzer Seer held its IPO on Nasdaq last November when it raised $ 175 million. Since then, the company’s share price has increased 242% to $ 65.90, giving a market value of $ 4.014 billion. Amoun’s stake in the company is $ 470 million. RELATED ARTICLES Amon & Roche for collaboration in digital health Automated solution to provide unbiased, deep, fast and scalable workflow solution for a clearer view of proteome. These solutions allow basic and multi-researchers to see the protein through a new lens that does not compromise their ability to see protein richness and diversity. AMoon partner and CFO Tomer Berkovitz said: “Seer wants to do for proteins (proteins) what has already been accomplished in genomics. Today mapping all proteins in a cell is a two-week process. Seer can do it in four hours. Using current methods, You can search for a specific protein that you know pre-exists. But here we talk about a lot more – we get a picture of all the proteins in the cell and their levels. ”The Amon Project closed $ 750 million in new funding in 2019 to invest in life sciences and healthcare. Like other Israeli venture capital funds in the sector, Amon is looking beyond Israel for worthwhile investments and recently led a $ 110m round of financing in Sophia Genetics, a Swiss company specializing in medical data. Posted by Globes, Israel business news – en.globes.co.il – February 7, 2021 © Copyright Globes Publisher Itonut (1983) Ltd. 2021


Like it? Share with your friends!

0

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
Mitchel

0 Comments

Your email address will not be published. Required fields are marked *